Perceptive Life Sciences Master Fund purchased 863,060 Immatics ordinary shares at $8.69 per share, leaving Perceptive Advisors LLC, the Master Fund and Joseph Edelman each reporting 11,418,016 shares, or 7.6%. For investors, the percentage’s stated basis matters because it uses 149,635,893 shares outstanding and assumes specified vested options.

Key Highlights

  • The Master Fund bought 863,060 Immatics ordinary shares at $8.69 each in an underwritten offering on August 26, 2026.
  • The 7.6% ownership calculation uses 149,635,893 ordinary shares outstanding and assumes exercise of vested Adam Stone options.
  • Perceptive reported ownership of 11,418,016 Immatics ordinary shares, equal to 7.6%.

Immatics N.V. (NASDAQ: IMTX) has a reported Perceptive position of 11,418,016 ordinary shares (11.4 million), equal to 7.6% of its outstanding ordinary shares. The Master Fund purchased 863,060 shares at $8.69 per share in Immatics’ underwritten offering on August 26, 2026.

$8.69 Offering Purchase

Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. and Joseph Edelman are each associated with the reported 11,418,016 ordinary shares and 7.6% interest. The securities are ordinary shares with a nominal value of EUR 0.01 per share. The Master Fund used its Working Capital for the purchase. The three reporting persons signed their respective documents on August 27, 2026.

Ownership Calculation Includes Vested Options

Immatics’ 7.6% percentage is calculated against 149,635,893 ordinary shares outstanding (149.6 million), as reported in a prospectus dated August 25, 2026.

Peers Moving on This News